Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities
The HPV vaccine is approved for children as young as age nine and recommended by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices routinely for ages 11-12. However, many U.S. adolescents do not complete the vaccine series until middle to late adolesc...
Saved in:
Main Authors: | Tamera Coyne-Beasley (Author), Rebecca R. Ortiz (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination
by: Rebecca R. Ortiz, et al.
Published: (2019) -
Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
by: Benjamin Z. Kahn, et al.
Published: (2023) -
How to make effective HPV vaccine recommendations starting at age 9
by: Noel T. Brewer, et al.
Published: (2023) -
Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9
by: Sean T. O'Leary
Published: (2022) -
Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study
by: Casey L. Daniel, et al.
Published: (2021)